Blurbs

Thermo Fisher (TMO) Gets a Buy Rating from SVB Securities

SVB Securities analyst Puneet Souda maintained a Buy rating on Thermo Fisher (TMOResearch Report) on July 14 and set a price target of $630.00. The company’s shares closed last Tuesday at $573.27.

According to TipRanks.com, Souda is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -9.6% and a 37.8% success rate. Souda covers the Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and Twist Bioscience.

Thermo Fisher has an analyst consensus of Strong Buy, with a price target consensus of $649.38, implying a 14.0% upside from current levels. In a report issued on July 13, Barclays also maintained a Buy rating on the stock with a $630.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Thermo Fisher’s market cap is currently $224.4B and has a P/E ratio of 29.89.

Based on the recent corporate insider activity of 79 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of TMO in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Thermo Fisher Scientific, Inc. provides analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services segments. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Read More on TMO:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos